Day: October 9, 2025

HOUSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) will announce its third quarter 2025 financial results after close of market on Monday, November 10, 2025, and will hold a conference call to discuss the results on Tuesday, November 11, 2025, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10202923/ffe6d67319. Third quarter 2025 financial results will be available through the Investor Relations section of the company’s website. A recording of the webcast will be posted on the website within several hours after the call is completed. About Occidental Occidental is an international energy company with assets...

Brings a wealth of financial leadership from world-class organizations such as Honeywell and Pfizer SOMERSET, N.J., Oct. 09, 2025 (GLOBE NEWSWIRE) — CompoSecure, Inc. (NYSE: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced the appointment of Mary Holt as Chief Financial Officer (CFO), effective the day immediately following the filing of the Company’s Q3 2025 Quarterly Report. She succeeds Tim Fitzsimmons who is retiring after a distinguished career with the company. As CFO, Ms. Holt will oversee CompoSecure’s finance organization, including financial planning and analysis; accounting and financial reporting; treasury and cash management; risk management and compliance; and investor relations. She will report directly to Jon Wilk, President and Chief Executive Officer of CompoSecure. Wilk...

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2025 financial results on Wednesday, November 5, 2025 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day. Conference Call Information Please visit the “Investors” page of the company’s website at https://www.royaltypharma.com/investors/events/ to obtain conference call information and to view the live webcast. A replay of the conference call and webcast will be archived on the company’s website for at least 30 days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating...

GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company, today announced the execution of a non-binding letter of Intent with Molecule.ai. Molecule.ai, a pioneering artificial intelligence company founded by AI scientist and researcher Dr. ZT Zhang, PhD, today announced the execution of a letter of Intent to acquire Molecule.ai and its state-of-the-art platform designed to transform the way pharmaceutical and biotech companies discover and develop new therapeutics. By leveraging advanced machine learning models, including large language models (LLMs), Molecule.ai delivers industry-leading accuracy and efficiency in evaluating novel molecules. The platform enables researchers to...

Not For Distribution to United States News Wire Services or Dissemination in United States CALGARY, Alberta, Oct. 09, 2025 (GLOBE NEWSWIRE) — Cavvy Energy Ltd. (“Cavvy” or the “Company”) (TSX:CVVY) will release its financial and operating results for the third quarter 2025 on Thursday, November 6, 2025, after market close. President & Chief Executive Officer Darcy Reding and Chief Financial Officer Adam Gray will discuss the financial results and company developments on an investor conference call and webcast on Friday, November 7, 2025, at 8:30 a.m. MDT / 10:30 a.m. EDT. To register to participate via webcast please follow this link: https://edge.media-server.com/mmc/p/rzdyekjc/  Alternatively, to register to participate by telephone please follow this link: https://register-conf.media-server.com/register/BIca286e95b11e4fa7aa39971e39b70b74 A...

EINDHOVEN, The Netherlands, Oct. 09, 2025 (GLOBE NEWSWIRE) — NXP Semiconductors N.V. (NASDAQ: NXPI) today announced it will release financial results for the third quarter 2025 after the close of normal trading on the NASDAQ Global Select Market on Monday, October 27, 2025. The company will host a conference call with the financial community on Tuesday, October 28, 2025, at 8:00 a.m. U.S. Eastern Daylight Time (EDT). Earnings Conference Call Details Interested parties may pre-register for the webcast or obtain a user-specific access code to join the live conference call. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call. About NXP Semiconductors  NXP Semiconductors N.V. (NASDAQ: NXPI) is the trusted partner for innovative solutions in the automotive, industrial &...

DOVER, USA, Oct. 09, 2025 (GLOBE NEWSWIRE) — Sunrise New Energy Co., Ltd. (“Sunrise,” the “Company,” “we,” or “our”) (NASDAQ: EPOW) today announced that its subsidiary, Sunrise (Guizhou) New Energy Materials Co., Ltd., has successfully co-developed an industry-leading CVD fluidized bed system for silicon-carbon anodes in collaboration with Songci Electromechanical Technology Co., Ltd., a holding subsidiary of AUTEWEI Technology Co., Ltd., a top-tier manufacturer in the photovoltaic and semiconductor equipment sectors. This achievement marks a major technological breakthrough in the industrialization of silicon-carbon anode materials and signifies a new milestone in Sunrise’s continuous innovation in advanced anode processing equipment, accelerating the commercialization of solid-state batteries. The collaboration combines Sunrise’s...

ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 2,250,000 shares of common stock (or pre-funded warrant in lieu thereof) and Series F warrants to purchase up to 4,500,000 shares of common stock at a purchase price of $2.00 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanying warrants in a private placement priced at-the-market under Nasdaq rules. The Series F warrants will have an exercise price of $1.75 per share and will be exercisable immediately upon issuance. The Series F warrants will expire 5.5 years from the date of issuance. The...

CARLSBAD, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) — In a release issued under the same headline on October 9th, by Premier Air Charter Holdings, Inc. (OTC ID: PREM), please note that the charter sales revenue and year-to-date charter revenue figures incorrectly listed 2024 instead of 2025. The corrected release follows: Premier Air Charter Holdings, Inc. (OTC ID: PREM) (“Premier Air Charter”, “Premier” or the “Company”), is pleased to announce another strong quarter, reflecting the company’s sustained momentum and strategic expansion across key markets. The latest results underscore Premier’s growing presence in both Hawaii and Mexico, driven by increased demand and effective execution of the Company’s regional growth initiatives. Premier Delivers Strong Charter Sales Growth Across Key Markets Premier Air Charter is proud to report...

Festi hf., kt. 540206-2010, Dalvegur 10-14, 201 Kópavogur, has published a base prospectus in connection with issuance programme for bonds and bills. The base prospectus, dated 9 October 2025, has been approved by the Financial Supervisory Authority of the Central Bank of Iceland. The prospectus is issued in Icelandic and published electronically on Festi’s website, https://www.festi.is/en/skuldabrefogvixlar. The Prospectus will be available on Festi’s website for ten years from the date of its approval. Íslandsbanki hf. managed the process of having the prospectus approved by the Financial Supervisory Authority of the Central Bank of Iceland. For further information, please contact Magnús Kr. Ingason, CFO of Festi hf. (mki@festi.is).AttachmentGrunnlýsing Festi 2025